BICAVERA FORTE 1.5% GLUCOSE 0.3675 G
CALCIUM CHLORIDE : 0.3675 G SODIUM CHLORIDE : 10.99 G MAGNESIUM CHLORIDE : 0.2033 G SODIUM BICARBONATE : 6.72 G DEXTROSE : 33.0 G · DIN 02269384 · FRESENIUS MEDICAL CARE CANADA INC
Health Canada status: CANCELLED PRE MARKET
What is BICAVERA FORTE 1.5% GLUCOSE?
BICAVERA FORTE 1.5% GLUCOSE 0.3675 G contains CALCIUM CHLORIDE : 0.3675 G SODIUM CHLORIDE : 10.99 G MAGNESIUM CHLORIDE : 0.2033 G SODIUM BICARBONATE : 6.72 G DEXTROSE : 33.0 G. It is listed in the Health Canada Drug Product Database under DIN 02269384, held by FRESENIUS MEDICAL CARE CANADA INC, supplied as SOLUTION for HAEMODIALYSIS administration. Health Canada currently lists it as cancelled pre market, status dated 28-Jul-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02269384 |
|---|---|
| Brand name | BICAVERA FORTE 1.5% GLUCOSE |
| Generic / active ingredient | CALCIUM CHLORIDE : 0.3675 G SODIUM CHLORIDE : 10.99 G MAGNESIUM CHLORIDE : 0.2033 G SODIUM BICARBONATE : 6.72 G DEXTROSE : 33.0 G |
| Manufacturer | FRESENIUS MEDICAL CARE CANADA INC |
| Strength | 0.3675 G |
| Dosage form | SOLUTION |
| Route of administration | HAEMODIALYSIS |
| Schedule | Ethical |
| ATC code | B05DB HYPERTONIC SOLUTIONS |
| AHFS class | 08:18.08.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 28-Jul-2020 |
| Original market date | 2005-08-17 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code B05DB HYPERTONIC SOLUTIONS. 3 of 21 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BALANCE 1.5% GLUCOSE, 1.25 MMOL/L CALCIUM | 0.1838 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | MARKETED | DIN 02261057 |
| BALANCE 2.3% GLUCOSE, 1.25 MMOL/L CALCIUM | 0.1838 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | MARKETED | DIN 02261073 |
| BALANCE 4.25% GLUCOSE, 1.25 MMOL/L CALCIUM | 0.1017 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | MARKETED | DIN 02261065 |
| BALANCE 1.5% GLUCOSE, 1.75 MMOL/L CALCIUM | 0.2573 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | APPROVED | DIN 02261022 |
| BALANCE 2.3% GLUCOSE, 1.75 MMOL/L CALCIUM | 0.2573 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | APPROVED | DIN 02261049 |
| BALANCE 4.25% GLUCOSE, 1.75 MMOL/L CALCIUM | 0.1017 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | APPROVED | DIN 02261030 |
| BICAVERA 1.5% GLUCOSE | 0.2573 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | CANCELLED PRE MARKET | DIN 02299682 |
| BICAVERA 2.3% GLUCOSE | 25.0 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | CANCELLED PRE MARKET | DIN 02299690 |
| BICAVERA 4.25% GLUCOSE | 5.786 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | CANCELLED PRE MARKET | DIN 02299704 |
| BICAVERA FORTE 2.3% GLUCOSE | 0.2033 G | SOLUTION | FRESENIUS MEDICAL CARE CANADA INC | CANCELLED PRE MARKET | DIN 02269392 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.